Samsung Biologics Dividend yield




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   KRW per share 
 Price  450,000.00
 Dividend  0.00
 Earnings  0.00
 Cash-flow  0.00
 Book value  61,643.84
 Equity  0.00

Samsung Biologics is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Samsung Biologics is a company from Korea, and his stocks are publicly traded.

Samsung Biologics paid a total dividend of 0 million KRW last year, for a market value of 29,700,000 millions (Market Cap 5,975,692 millions). Dividend per share of Samsung Biologics is 0.00 KRW, and his stock market price 450,000.00 KRW.

According to the chart below where dividend yield is displayed, Samsung Biologics, has a dividend yield of 0%, amount in contrast with the positive dividend offered by both the market average and companies from Korea, Health Care industry, and Pharmaceuticals and Biotechnology sector. This lack of dividends of Samsung Biologics might harm the evolution of share price if the company is not clearly expanding his business.

In addition, you should compare Samsung Biologics dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Korea.

Dividend yield of Samsung Biologics

Samsung Biologics Dividend Payout

About the ability of Samsung Biologics to maintain his current dividend of KRW 0.00 per share, an amount that accounts for 0.00%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Samsung Biologics payout on ernings is currently 0.00%, which is lower than the market average and companies in his industry and sector.

The following figure shows payout ratios over earnings and cashflow of Samsung Biologics, compared againt world market average, Korea companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies. You might also need to check full financial report of Samsung Biologics.

Samsung Biologics payout

Samsung Biologics Stock performance

Finally, last moth Samsung Biologics showed a return of 2.60% compared to a worldwide -3.60% average, and a -3.29% of Health Care firms. Over the last year, the company obtained a 173.60% versus a worldwide performance of a 13.88%. More detailed information can be seen in the following graph for Korea and Pharmaceuticals and Biotechnology firms.

Samsung Biologics stock and market return

Next companies

Samsung Card. Korea. Financials.

Samsung Electro-Mech. Korea. Industrials.

Samsung Electronics. Korea. Consumer Goods.

Samsung Eng. Korea. Industrials.

Samsung F & M Ins. Korea. Financials.

Samsung Fine Chem. Korea. Basic Materials.

Previous companies

Samsonite Internatio. Hong-Kong. Consumer Goods.

Sampo Oyi. Finland. Financials.

Salvatore Ferragamo. Italy. Consumer Goods.

Salesforce.com. USA. Technology.

Saipem. Italy. Oil and Gas.

Sainsbury (J). UK. Consumer Services.

 

 

All rights reserved

 information advertisement legal

Dividends Ranking | Firm Report | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.